Results 101 to 110 of about 60,579 (161)

International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges. [PDF]

open access: yesNeurol Ther
Chan A   +11 more
europepmc   +1 more source

Treatment-free remission in MS: long-term disease control with cladribine tablets. [PDF]

open access: yesJ Neurol
Wiendl H   +10 more
europepmc   +1 more source

Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report. [PDF]

open access: yesJ Med Case Rep
Sahbani F   +7 more
europepmc   +1 more source

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial). [PDF]

open access: yesJNCI Cancer Spectr
Agustoni F   +14 more
europepmc   +1 more source

Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia. [PDF]

open access: yesJ Hum Immun
Ghosh S   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy